Y. Okubo

Antibody Screening System Using a Herpes Simplex Virus (HSV)-Based Probe To Identify a Novel Target for Receptor-Retargeted Oncolytic HSVs

M. Yamaguchi, H. Hamada, Masato Tanaka, 2021, Journal of Virology.

Development of an oncolytic HSV vector fully retargeted specifically to cellular EpCAM for virus entry and cell-to-cell spread

M. Yamaguchi, J. B. Cohen, H. Hamada, 2016, Gene Therapy.

Induction of the 2B9 antigen/dipeptidyl peptidase IV/CD26 on human natural killer cells by IL‐2, IL‐12 or IL‐15

T. Yamabe, J. Yodoi, S. Takeda, 1997, Immunology.

Successful Amplified-Natural-Killer Cell (ANK) Therapy Administered to a Patient with Smoldering Adult T-Cell Leukemia in Acute Crisis

H. Chagan-Yasutan, T. Hattori, G. Bai, 2018, Reports.

Syncytial Mutations Do Not Impair the Specificity of Entry and Spread of a Glycoprotein D Receptor-Retargeted Herpes Simplex Virus

M. Yamaguchi, H. Hamada, M. Tagaya, 2016, Journal of Virology.

Glycophorin B as an EBA-175 independent Plasmodium falciparum receptor of human erythrocytes.

D. Alling, T. Wellems, L. Miller, 1994, Molecular and biochemical parasitology.

Falciparum malaria parasites invade erythrocytes that lack glycophorin A and B (MkMk). Strain differences indicate receptor heterogeneity and two pathways for invasion.

J. Haynes, L. Miller, G. Pasvol, 1987, The Journal of clinical investigation.